Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer

Nearly one-third of patients with high-grade serous ovarian cancer (HGSC) do not respond to initial treatment with platinum-based therapy. Genomic and clinical characterization of these patients may lead to potential alternative therapies. Here, the objective is to classify non-responders into subse...

Descripción completa

Detalles Bibliográficos
Autores principales: McDonald, Megan E., Salinas, Erin A., Devor, Eric J., Newtson, Andreea M., Thiel, Kristina W., Goodheart, Michael J., Bender, David P., Smith, Brian J., Leslie, Kimberly K., Gonzalez-Bosquet, Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429334/
https://www.ncbi.nlm.nih.gov/pubmed/30866519
http://dx.doi.org/10.3390/ijms20051175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429334/
https://www.ncbi.nlm.nih.gov/pubmed/30866519
http://dx.doi.org/10.3390/ijms20051175

Ejemplares similares